Stock Price
6.10
Daily Change
-1.03 -14.45%
Monthly
-19.74%
Yearly
39.59%
Q2 Forecast
5.99

Silence Therapeutics reported $12.5M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AstraZeneca USD 8.18B 4.35B Mar/2026
Autolus Therapeutics Ltd USD 85.73M 11.02M Mar/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Novartis USD 9.29B 507M Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Silence Therapeutics USD 12.5M 13.91M Dec/2025